Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: AARON DIDICH who wrote (178)	11/15/1997 2:44:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 569

<<<<<<Those patients that come to surgery have the tab picked up by the carrier and get the first injection after the physician completes his arthroscope. .......just think if many of the scope procedures were followed by synvisc injections--could make the ortho a hero when the patient says the surgery was a miracle!!!!! .......for the couple hundred bucks this could really explode as a final procedure to many knee scopes. ..thanks for the info!!!

To: AARON DIDICH who wrote (178)	11/15/1997 7:27:00 AM
From: James Baker	Read Replies (1) \| Respond to of 569

Aaron, those of us waiting for Synvisc roll out would be interested to know where you are located (US, Canada, Europe???) and what the experience and acceptance of docs and patients seems to be. We all believe that the roll out is just beginning in the US after FDA approval MANY months ago. The potential market for Synvisc seems to be huge but the acceptance first by docs so that they will suggest/recommend it to patients is critical. Patient word of mouth and some good news articles will further the patient awareness. Thanks for the info. Jim

To: AARON DIDICH who wrote (178)	11/15/1997 1:00:00 PM
From: John McCarthy	Read Replies (2) \| Respond to of 569

Aaron If it does NOT require you to cross any medical, ethical, moral, or just plain old good personal boundries that you have, I would appreciate any feedback that you could provide in terms of the Synvisc success/failure rate that you see/experience. In terms of a simple (%). Without justifying my guess, I am getting a sense that - overall - Synvisc will work for the general population somewhere between 75% - 85%. My gut is telling me that if Synvisc stays above a 70% success rate then (1) word of mouth and (2) all the GOOD PRESS we could hope for will just come our way. Regards, John McCarthy